HF
PALI icon

HRT Financial’s Palisade Bio PALI Stock Holding History

HRT Financial’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-211,882
Closed -$370K – 5052
2026
Q1 		$370K Buy
+211,882
New +$385K ﹤0.01% 2725
2025
Q2 		– Sell
-18,264
Closed -$12K – 3309
2025
Q1 		$12K Buy
+18,264
New +$21.6K ﹤0.01% 2341
2024
Q2 		– Sell
-2,155
Closed -$12K – 2869
2024
Q1 		$12K Buy
+2,155
New +$15K ﹤0.01% 2053
2020
Q3 		– Sell
-3
Closed -$8K – 2233
2020
Q2 		$8K Buy
+3
New +$10.8K ﹤0.01% 1481

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HRT Financial's PALI Position: Q2 2026 in Review

HRT Financial sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 211,882 shares — an estimated $370K sold.

HRT Financial first reported a position in PALI in Q2 2020 and held it in 4 quarters. The position peaked at $370K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • HRT Financial reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 211,882 Palisade Bio shares in Q2 2026, an estimated $370K.
  • HRT Financial first reported a position in Palisade Bio in Q2 2020 and held it in 4 quarters.
  • HRT Financial's Palisade Bio position peaked at $370K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.